Vanguard Group’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$494M Buy
33,960,320
+5,359,710
+19% +$93.5M 0.01% 1072
2025
Q3
$513M Buy
28,600,610
+1,351,395
+5% +$19.8M 0.01% 1055
2025
Q2
$465M Buy
27,249,215
+6,671,115
+32% +$66.8M 0.01% 1070
2025
Q1
$149M Buy
20,578,100
+1,199,448
+6% +$13.7M ﹤0.01% 1615
2024
Q4
$272M Buy
19,378,652
+6,819,406
+54% +$101M ﹤0.01% 1387
2024
Q3
$149M Buy
12,559,246
+2,810,588
+29% +$29.1M ﹤0.01% 1692
2024
Q2
$90.7M Buy
9,748,658
+3,541,567
+57% +$18.1M ﹤0.01% 1878
2024
Q1
$22M Buy
+6,207,091
New +$21.5M ﹤0.01% 2551

Other funds holding CORZ

Vanguard Group's CORZ Position: Q4 2025 in Review

Vanguard Group increased its Core Scientific (CORZ) stake by 19% in Q4 2025, buying an estimated $93.5M and bringing the position to 33,960,320 shares worth $494M. The position accounts for 0.01% of the portfolio, ranked #1072.

Vanguard Group first reported a position in CORZ in Q1 2024 and has held it in 8 quarters since. The position peaked at $513M in Q3 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • Vanguard Group held 33,960,320 shares of Core Scientific worth $494M as of Q4 2025.
  • Vanguard Group bought 5,359,710 Core Scientific shares in Q4 2025, an estimated $93.5M.
  • Core Scientific made up 0.01% of Vanguard Group's portfolio in Q4 2025, its #1072 holding.
  • Vanguard Group first reported a position in Core Scientific in Q1 2024 and has held it in 8 quarters since.
  • Vanguard Group's Core Scientific position peaked at $513M in Q3 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.